|
Model Number 106 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Bradycardia (1751); Asystole (4442)
|
Event Date 11/22/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
|
|
Event Description
|
On (b)(6) 2022, full replacement was performed for patient.During the surgery, the patient experienced bradycardia and cardiac arrest at the time of stimulation tests with new generator and lead.Therefore the new generator and lead were not implanted.Bradycardia and cardiac arrest occurred when the patient was given a test stimulation of 1.0 ma with new m106 (s/n (b)(4)) and lead m304-20 (s/n (b)(4)).It was originally 85 bpm to 90 bpm, but dropped to around 60 bpm during testing.Cardiac arrest occurred when test stimulation was performed again at 2.75ma.Therefore, transcutaneous pacing was performed.When the lead coil was moved in the caudal direction and test stimulation was performed again at 1.0 ma, cardiac arrest occurred again, and percutaneous pacing was performed again.Physicians determined that it would be difficult to complete the implant in this situation.He removed the new generator and lead from the patient body and closed the wound.The products are scheduled for return and confirmed shipped but have not been received to date.Device history records were reviewed.The devices were confirmed to have passed all functional and quality tests and were hp sterilized prior to distribution.No other relevant information has been received to date.This mdr houses the report of arrythmia asystole and arrythmia bradycardia on the generator that was not implanted.
|
|
Event Description
|
The device has been received into product analysis.Product analysis is underway but not yet completed.No other relevant information has been received to date.
|
|
Event Description
|
The physician has reported that the events are believed to be related to vns stimulation, that the device was functioning as intended, it was used as usual, and no particular problems occurred with the device.Intervention was taken using percutaneous pacing and the patient was not hospitalized.The event has not recurred.Arrhythmia events related to vns stimulation are a known inherent risk of the device addressed in labeling.No other relevant information has been received to date.
|
|
Event Description
|
Generator product analysis was approved for the device.There were no performance, or any other type of adverse conditions found with the pulse generator.No anomalies were seen, and the device performed according to functional specifications.No other relevant information has been received to date.
|
|
Search Alerts/Recalls
|
|
|